Depression and anxiety in age-related macular degeneration

Eung Suk Kim,1 Yonguk Kim,1 Seung-Young Yu,1 Moosang Kim2 1Department of Ophthalmology, Kyung Hee University Hospital, Kyung Hee University, Seoul, 2Department of Ophthalmology, School of Medicine, Kangwon National University, Chuncheon, Korea We read with great interest the article titled “Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting” by Gohil et al.1 We are in agreement with their findings. We congratulate the authors for their well-organized study and would like to contribute to their findings. View the original paper by Gohill and colleagues.